A high‐throughput TREC‐ and KREC ‐based newborn screening for severe inborn errors of immunity
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.15872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 23.03.2025. Verfasst von Haruka Hiroki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo…. Hauptthemen laut MEDLINE: Neonatal Screening, Severe Combined Immunodeficiency, High-Throughput Screening Assays, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Introduction
Severe combined immunodeficiency (SCID) due to T‐cell deficiency is the most severe form of inborn error of immunity (IEI). It frequently leads to severe and recurrent infections and the first infection or live vaccines can sometimes be fatal. Patients with B‐cell deficiency (BCD), such as X‐linked agammaglobulinaemia (XLA), also suffer from severe or recurrent infections. Thus, early diagnosis via newborn screening (NBS) is suitable for these types of diseases. We developed a lyophylized TaqMan‐based quantitative polymerase chain reaction (qPCR) kit with primers and probes for the simultaneous detection of T‐cell receptor excision circles (TREC) and κ‐deleting recombination excision circles (KREC). We also developed a fully automated DNA extraction and purification process using Magtration technology from dried blood spots (DBS), enabling high‐throughput analysis Methods We examined 15,258 stored DBS collected from 2014 to 2015 by this method. Newborn screening samples from children with a known SCID, XLA or ataxia‐telangiectasia (AT) were also examined as positive controls.
Results
RPPH1 (internal control), TREC, and KREC all had near‐normal distributions. One specimen was below the cut‐off for TREC (0.00657%) after exclusion of 36 specimens due to the failure of DNA extraction (0.23%). The TREC levels in the patients with AT and SCID, and KREC levels in the patients with AT and XLA were all below cut‐off or absent.
Conclusions
This assay would allow the establishment of qPCR‐based NBS in unfamiliar laboratories leading to the early diagnosis of SCID and BCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
- Department of Pediatrics, National Defense Medical College, Saitama, Japan.
- Department of Human Genetics, National Center for Child Health and Development, Tokyo, Japan.
- Shimadzu Diagnostics Co., Ltd., Yuki-shi, Ibaraki, Japan.
- Center for Stem Cell and Regenerative Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
- Tsukuba Oligo Service Co., Ltd, Ushiku, Ibaraki, Japan.
ORCID-Profile: Kunihiko Moriya, Kohsuke Imai
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Ministry of Health, Labour and Welfare
Zitieren
APA
Hiroki, H., Moriya, K., Uchiyama, T., Hirose, F., Endo, A., Sato, I., Tomaru, Y., Sawakami, K., Shimizu, N., Ohnishi, H., Morio, T., & Imai, K. (2025). A high‐throughput TREC‐ and KREC ‐based newborn screening for severe inborn errors of immunity. Pediatrics International, 67(1). https://doi.org/10.1111/ped.15872
Vancouver
Hiroki H, Moriya K, Uchiyama T, Hirose F, Endo A, Sato I, et al. A high‐throughput TREC‐ and KREC ‐based newborn screening for severe inborn errors of immunity. Pediatrics International. 2025;67(1). doi:10.1111/ped.15872
BibTeX
@article{Hiroki2025,
author = {Hiroki, Haruka and Moriya, Kunihiko and Uchiyama, Toru and Hirose, Fumi and Endo, Akifumi and Sato, Iori and Tomaru, Yasuhiro and Sawakami, Kazumi and Shimizu, Norio and Ohnishi, Hidenori and Morio, Tomohiro and Imai, Kohsuke},
title = {A high‐throughput TREC‐ and KREC ‐based newborn screening for severe inborn errors of immunity},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.15872}
}
EUVIMED